About Glamorous AI
Glamorous AI is a Healthcare company based in London (United Kingdom) founded in 2020, and was acquired by X-Chem in October 2021. Preclinical studies for biopharma drug discovery are conducted. Glamorous AI offers products and services including DEL Screening, ReadiDEL, ReadiBLOX, ArtemisAI, and HITMiner. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified.
Company details
Glamorous AI was founded in 2020 and is based in London, United Kingdom. Operations focus on the biopharma sector, where preclinical studies are conducted to support drug discovery processes. Services include analysis and testing in early-stage research, aiding pharmaceutical companies in development pipelines. The company maintains a domain at glamorous.ai for its digital presence.
- Headquarters London, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website glamorous.ai
- Social LinkedIn X
- Acquired by X-Chem (Oct 2021)
Products & Services of Glamorous AI
Glamorous AI offers a comprehensive portfolio of products and services, including DEL Screening, ReadiDEL, ReadiBLOX, ArtemisAI, and HITMiner.
Screening platform for identifying small molecule hits using DNA libraries.
Pre-built library for rapid drug discovery applications.
Modular blocks for custom medicinal chemistry synthesis.
AI tool for analyzing molecular interactions in drug discovery.
Platform for mapping compounds and expanding hits in research.
Investors in Glamorous AI
Glamorous AI has secured backing from 1 investor. Prominent investors backing the company include X-Chem.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Small molecule drug discovery platform is provided to researchers. | 2009 | x-chemrx.com | Waltham, United States |
Investor details for Glamorous AI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Glamorous AI
2 dated milestones of Glamorous AI across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Glamorous AI is founded.
- Exit Acquired by X-Chem.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Glamorous AI
Glamorous AI was founded in 2020.
Glamorous AI is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Glamorous AI was founded in 2020 and is based in London, United Kingdom. Operations focus on the biopharma sector, where preclinical studies are conducted to support drug discovery processes. Services include analysis and testing in early-stage research, aiding pharmaceutical companies in development pipelines. The company maintains a domain at glamorous.ai for its digital presence.
Glamorous AI offers DEL Screening, ReadiDEL, ReadiBLOX, ArtemisAI, and HITMiner.
Glamorous AI has 1 investor. Key investors include X-Chem.
Yes. Glamorous AI was acquired by X-Chem in October 2021.
